Helicobacter pylori infection and risk of cardiovascular disease

Abstract

AbstractBackgroundWhether Helicobacter pylori (H. pylori) infection is associated with an increased risk of cardiovascular disease (CVD) remains controversial. This study aimed to investigate the association between H. pylori infection and the risk of CVD.MethodsPotentially related studies were searched in the electronic databases, including PubMed, EMBASE and Cochrane Library, from inception to 31 August 2022. Observational cohort studies that reported the multivariable‐adjusted relative risks (RRs) for composite CVD, CHD, stroke, or all‐cause mortality associated with H. pylori infection were included in the meta‐analysis, using random‐effects models.ResultsForty‐one cohort studies with 230,288 participants were included. After a median follow‐up duration of 6.3 years, H. pylori infection was associated with a mildly increased risk of composite CVD (RR 1.10, 95% CI 1.03, 1.18) and coronary heart disease (RR 1.10, 95% CI 1.02, 1.18) compared with those without H. pylori infection. No significant association was observed between H. pylori infection and risk of stroke (RR 1.08, 95% CI 0.94, 1.23) or all‐cause mortality (RR 1.02, 95% CI 0.90, 1.16). Compared with cytotoxin‐associated gene‐A (CagA) negative H. pylori infection, the risk of CVD was significantly increased in patients with CagA positive H. pylori infection (RR 1.58, 95% CI 1.03, 2.41).ConclusionsHelicobacter pylori infection is associated with a mildly increased risk of CVD. It may be of great public health and clinical significance to screen H. pylori infection in patients with a high risk of CVD.